Statements (27)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:activeIngredient |
gptkb:metformin
|
gptkbp:approvalYear |
2005
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:ATCCode |
A10BA02
|
gptkbp:brand |
gptkb:metformin_hydrochloride_extended-release
|
gptkbp:contraindication |
severe renal impairment
metabolic acidosis |
gptkbp:form |
extended-release tablet
1000 mg tablet 500 mg tablet |
https://www.w3.org/2000/01/rdf-schema#label |
Glumetza XR
|
gptkbp:indication |
improving glycemic control
|
gptkbp:legalStatus |
Rx-only (US)
|
gptkbp:manufacturer |
gptkb:Bausch_Health
|
gptkbp:marketedIn |
gptkb:United_States
|
gptkbp:mechanismOfAction |
decreases hepatic glucose production
increases insulin sensitivity decreases intestinal absorption of glucose |
gptkbp:pregnancyCategory |
B (US)
|
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
gastrointestinal upset
lactic acidosis |
gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
gptkbp:bfsParent |
gptkb:DB00170
|
gptkbp:bfsLayer |
6
|